SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 50 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,860 | +39.2% | 97,786 | +86.8% | 0.00% | – |
| Q2 2023 | $131,361 | -53.8% | 52,335 | -67.8% | 0.00% | – |
| Q1 2023 | $284,265 | +2654.8% | 162,437 | +6590.2% | 0.00% | – |
| Q4 2022 | $10,319 | -82.2% | 2,428 | -95.1% | 0.00% | – |
| Q3 2022 | $58,000 | -7.9% | 49,245 | -22.2% | 0.00% | – |
| Q2 2022 | $63,000 | -68.7% | 63,336 | -22.9% | 0.00% | – |
| Q1 2022 | $201,000 | -35.8% | 82,194 | -29.3% | 0.00% | – |
| Q4 2021 | $313,000 | -49.8% | 116,303 | -6.5% | 0.00% | – |
| Q3 2021 | $623,000 | -33.1% | 124,341 | -0.4% | 0.00% | – |
| Q2 2021 | $931,000 | +26.0% | 124,794 | -0.9% | 0.00% | – |
| Q1 2021 | $739,000 | +13.7% | 125,973 | -8.9% | 0.00% | – |
| Q4 2020 | $650,000 | +34.0% | 138,287 | -1.9% | 0.00% | – |
| Q3 2020 | $485,000 | – | 140,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |